ReviewThe Lancet. Infectious diseases2019

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens.

Seth C Inzaule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.